Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma, Malignant × toripalimab × 1 year × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 12 Nasopharyngeal Carcinoma 11 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Renal Cell 5 Advanced Solid Tumor 5 Uterine Cervical Neoplasms 4 Recurrence 4 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Solid Tumor 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 NSCLC 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stage IB-IIIB NSCLC 1 Solid Tumor, Adult 1 Solid Cancer 1

Interventions

Cisplatin 15 Pemetrexed 12 pembrolizumab 8 Nivolumab 8 Carboplatin 7 Ipilimumab 5 Cyclophosphamide 5 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Gemcitabine 3 Drug Therapy 3 tremelimumab 2 fludarabine 2 durvalumab 2 atezolizumab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiation 2 Photochemotherapy 2 Methotrexate 2 Interleukin-2 2 Chemotherapy, Adjuvant 2 sargramostim 1 olaparib 1 niraparib 1 nintedanib 1 methoxyamine 1 lenvatinib 1 enzalutamide 1 decitabine and cedazuridine drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡